• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孟加拉国成年霍乱患者对霍乱弧菌O1型特异性多糖和脂多糖免疫反应的比较。

Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.

作者信息

Johnson Russell A, Uddin Taher, Aktar Amena, Mohasin M, Alam Mohammad Murshid, Chowdhury Fahima, Harris Jason B, LaRocque Regina C, Bufano Meagan Kelly, Yu Yanan, Wu-Freeman Ying, Leung Daniel T, Sarracino David, Krastins Bryan, Charles Richelle C, Xu Peng, Kovác Pavol, Calderwood Stephen B, Qadri Firdausi, Ryan Edward T

机构信息

Centre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.

出版信息

Clin Vaccine Immunol. 2012 Nov;19(11):1712-21. doi: 10.1128/CVI.00321-12. Epub 2012 Sep 19.

DOI:10.1128/CVI.00321-12
PMID:22993410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3491541/
Abstract

Immunity against Vibrio cholerae O1 is serogroup specific, and serogrouping is defined by the O-specific polysaccharide (OSP) part of lipopolysaccharide (LPS). Despite this, human immune responses to V. cholerae OSP have not previously been characterized. We assessed immune responses against V. cholerae OSP in adults with cholera caused by V. cholerae O1 El Tor serotype Inaba or Ogawa in Dhaka, Bangladesh, using O1 OSP-core-bovine serum albumin (OSPc:BSA) conjugates; responses targeted OSP in these conjugates. Responses of Inaba-infected patients to Inaba OSP and LPS increased significantly in IgG, IgM, and IgA isotypes from the acute to convalescent phases of illness, and the responses correlated well between OSP and LPS (R = 0.86, 0.73, and 0.91, respectively; P < 0.01). Plasma IgG, IgM, and IgA responses to Ogawa OSP and LPS in Ogawa-infected patients also correlated well with each other (R = 0.60, 0.60, and 0.92, respectively; P < 0.01). Plasma IgM responses to Inaba OSP and Ogawa OSP correlated with the respective serogroup-specific vibriocidal antibodies (R = 0.80 and 0.66, respectively; P < 0.001). Addition of either OSPc:BSA or LPS, but not BSA, to vibriocidal assays inhibited vibriocidal responses in a comparable and concentration-dependent manner. Mucosal IgA immune responses to OSP and LPS were also similar. Our study is the first to characterize anti-OSP immune responses in patients with cholera and suggests that responses targeting V. cholerae LPS, including vibriocidal responses that correlate with protection against cholera, predominantly target OSP. Induction of anti-OSP responses may be associated with protection against cholera, and our results may support the development of a vaccine targeting V. cholerae OSP.

摘要

针对霍乱弧菌O1的免疫具有血清群特异性,血清群分类由脂多糖(LPS)的O特异性多糖(OSP)部分决定。尽管如此,此前人类对霍乱弧菌OSP的免疫反应尚未得到表征。我们在孟加拉国达卡对由霍乱弧菌O1埃尔托血清型稻叶或小川引起霍乱的成人中,使用O1 OSP-核心-牛血清白蛋白(OSPc:BSA)偶联物评估了针对霍乱弧菌OSP的免疫反应;反应针对这些偶联物中的OSP。稻叶感染患者对稻叶OSP和LPS的反应在疾病急性期到恢复期的IgG、IgM和IgA同种型中显著增加,并且OSP和LPS之间的反应相关性良好(分别为R = 0.86、0.73和0.91;P < 0.01)。小川感染患者血浆中对小川OSP和LPS的IgG、IgM和IgA反应彼此之间也相关性良好(分别为R = 0.60、0.60和0.92;P < 0.01)。血浆中对稻叶OSP和小川OSP的IgM反应与各自血清群特异性的杀弧菌抗体相关(分别为R = 0.80和0.66;P < 0.001)。在杀弧菌试验中添加OSPc:BSA或LPS,但不添加BSA,以类似且浓度依赖的方式抑制杀弧菌反应。对OSP和LPS的黏膜IgA免疫反应也相似。我们的研究首次表征了霍乱患者的抗OSP免疫反应,并表明针对霍乱弧菌LPS的反应,包括与预防霍乱相关的杀弧菌反应,主要针对OSP。抗OSP反应的诱导可能与预防霍乱有关,我们的结果可能支持开发针对霍乱弧菌OSP的疫苗。

相似文献

1
Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.孟加拉国成年霍乱患者对霍乱弧菌O1型特异性多糖和脂多糖免疫反应的比较。
Clin Vaccine Immunol. 2012 Nov;19(11):1712-21. doi: 10.1128/CVI.00321-12. Epub 2012 Sep 19.
2
Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.口服霍乱疫苗 CVD103-HgR 接种后的抗-O 特异性多糖(OSP)免疫应答与感染野生型霍乱弧菌 O1 埃尔托 因 巴氏后对霍乱的保护作用相关,这在北美的志愿者中得到了证实。
PLoS Negl Trop Dis. 2018 Apr 6;12(4):e0006376. doi: 10.1371/journal.pntd.0006376. eCollection 2018 Apr.
3
Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.针对 O 特异性多糖(OSP)的血浆和记忆 B 细胞反应与孟加拉国霍乱患者家庭接触者对霍乱弧菌 O1 感染的保护有关。
PLoS Negl Trop Dis. 2018 Apr 23;12(4):e0006399. doi: 10.1371/journal.pntd.0006399. eCollection 2018 Apr.
4
Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba.北美感染霍乱弧菌 O1 型 Inaba 血清型的成年人对 O 特异性多糖 (OSP) 的免疫应答。
PLoS Negl Trop Dis. 2019 Nov 19;13(11):e0007874. doi: 10.1371/journal.pntd.0007874. eCollection 2019 Nov.
5
O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.孟加拉国感染霍乱弧菌O1小川型的幼儿、大龄儿童及成人中O特异性多糖特异性记忆B细胞反应
Clin Vaccine Immunol. 2016 May 6;23(5):427-435. doi: 10.1128/CVI.00647-15. Print 2016 May.
6
Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.在孟加拉国,口服口服灭活全细胞霍乱疫苗后,诱导成人针对霍乱弧菌 O1 O 特异性多糖(OSP)的全身、黏膜和记忆抗体反应。
PLoS Negl Trop Dis. 2019 Aug 1;13(8):e0007634. doi: 10.1371/journal.pntd.0007634. eCollection 2019 Aug.
7
Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.孟加拉国成年口服霍乱死疫苗接种者对霍乱弧菌O1小川型O特异性多糖和脂多糖的免疫反应及其与霍乱患者反应的比较。
Am J Trop Med Hyg. 2014 May;90(5):873-81. doi: 10.4269/ajtmh.13-0498. Epub 2014 Mar 31.
8
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.在感染 O139 霍乱弧菌和接种商业双价口服霍乱疫苗后,针对人类 O139 霍乱弧菌的多糖特异性抗体靶点的定义,以及针对 O139 的结合疫苗的评估。
mSphere. 2021 Aug 25;6(4):e0011421. doi: 10.1128/mSphere.00114-21. Epub 2021 Jul 7.
9
Comparison of O-specific polysaccharide responses in patients following infection with O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh.孟加拉国感染 O139 血清型与接种二价(O1/O139)口服霍乱死疫苗后患者 O 特异性多糖反应的比较。
mSphere. 2023 Oct 24;8(5):e0025523. doi: 10.1128/msphere.00255-23. Epub 2023 Aug 30.
10
Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.口服全细胞霍乱疫苗后,用霍乱弧菌O1小川型合成六糖共轭物进行经皮免疫可增强杀弧菌反应并在小鼠中诱导保护性免疫。
Clin Vaccine Immunol. 2012 Apr;19(4):594-602. doi: 10.1128/CVI.05689-11. Epub 2012 Feb 22.

引用本文的文献

1
Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge.针对福氏志贺菌 6 型的志贺氏菌结合疫苗的开发,该疫苗具有免疫原性,能提供针对强毒力挑战的保护。
Vaccine. 2024 Oct 24;42(24):126263. doi: 10.1016/j.vaccine.2024.126263. Epub 2024 Aug 31.
2
Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population.在地方性流行人群中口服霍乱疫苗再次接种的前90天内杀弧菌抗体的血清转化及动力学
Vaccines (Basel). 2024 Apr 8;12(4):390. doi: 10.3390/vaccines12040390.
3
Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.Euvichol-S 口服霍乱疫苗预防尼泊尔 O1 群霍乱弧菌感染的安全性和免疫原性:一项观察者盲法、活性对照、随机、非劣效性、3 期临床试验。
Lancet Glob Health. 2024 May;12(5):e826-e837. doi: 10.1016/S2214-109X(24)00059-7.
4
Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.口服 Dukoral 霍乱疫苗后不同年龄组孟加拉参与者的霍乱毒素和 O 特异性多糖免疫应答。
mSphere. 2024 Mar 26;9(3):e0056523. doi: 10.1128/msphere.00565-23. Epub 2024 Feb 23.
5
Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1.用包含 O 特异性多糖和破伤风毒素重链重组片段的霍乱结合疫苗给兔子接种可诱导针对霍乱弧菌 O1 的保护性免疫应答。
Am J Trop Med Hyg. 2023 Oct 2;109(5):1122-1128. doi: 10.4269/ajtmh.23-0259. Print 2023 Nov 1.
6
Comparison of O-specific polysaccharide responses in patients following infection with O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh.孟加拉国感染 O139 血清型与接种二价(O1/O139)口服霍乱死疫苗后患者 O 特异性多糖反应的比较。
mSphere. 2023 Oct 24;8(5):e0025523. doi: 10.1128/msphere.00255-23. Epub 2023 Aug 30.
7
Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry.利用新型平台偶联技术——丁烯二酸化学法,研制针对福氏 2a 亚型和福氏 3a 亚型志贺菌的志贺菌结合疫苗。
Vaccine. 2023 Jul 31;41(34):4967-4977. doi: 10.1016/j.vaccine.2023.06.052. Epub 2023 Jul 1.
8
Calibration of a serum reference standard for Group B streptococcal polysaccharide conjugate vaccine development using surface plasmon resonance.使用表面等离子体共振对B族链球菌多糖结合疫苗开发的血清参考标准品进行校准。
NPJ Vaccines. 2023 May 19;8(1):71. doi: 10.1038/s41541-023-00667-1.
9
Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh.自然感染霍乱后唾液酸酶的长期特异性免疫反应:来自孟加拉国纵向队列研究的结果。
Front Immunol. 2022 Dec 22;13:1067737. doi: 10.3389/fimmu.2022.1067737. eCollection 2022.
10
Molecular Basis of the Toxigenic Vibrio cholerae O1 Serotype Switch from Ogawa to Inaba in Haiti.海地产致毒霍乱弧菌 O1 血清型从稻叶型到小川型的转变的分子基础。
Microbiol Spectr. 2023 Feb 14;11(1):e0362422. doi: 10.1128/spectrum.03624-22. Epub 2022 Dec 20.

本文引用的文献

1
Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in gram-positive and gram-negative bacteria.氨基酸添加到霍乱弧菌 LPS 中建立了革兰氏阳性和革兰氏阴性细菌表面重塑之间的联系。
Proc Natl Acad Sci U S A. 2012 May 29;109(22):8722-7. doi: 10.1073/pnas.1201313109. Epub 2012 May 15.
2
Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh.记忆B细胞对霍乱弧菌O1脂多糖的反应与孟加拉国霍乱患者家庭接触者预防感染相关。
Clin Vaccine Immunol. 2012 Jun;19(6):842-8. doi: 10.1128/CVI.00037-12. Epub 2012 Apr 18.
3
Immune responses to cholera in children.儿童对霍乱的免疫反应。
Expert Rev Anti Infect Ther. 2012 Apr;10(4):435-44. doi: 10.1586/eri.12.23.
4
Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.与孟加拉国自然感染霍乱后的反应相比,接受两剂口服灭活霍乱疫苗的儿童的记忆B细胞和其他免疫反应。
Clin Vaccine Immunol. 2012 May;19(5):690-8. doi: 10.1128/CVI.05615-11. Epub 2012 Mar 21.
5
Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines.简单、直接地将细菌 O-SP 核心抗原与蛋白质偶联:开发霍乱结合疫苗。
Bioconjug Chem. 2011 Oct 19;22(10):2179-85. doi: 10.1021/bc2001984. Epub 2011 Sep 30.
6
Natural cholera infection-derived immunity in an endemic setting.在流行地区,天然霍乱感染获得的免疫力。
J Infect Dis. 2011 Sep 15;204(6):912-8. doi: 10.1093/infdis/jir416.
7
Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans.霍乱弧菌O1感染在受感染人类的血液和肠道黏膜中诱导促炎性CD4+ T细胞反应。
Clin Vaccine Immunol. 2011 Aug;18(8):1371-7. doi: 10.1128/CVI.05088-11. Epub 2011 Jun 22.
8
Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.孟加拉国成年人在接种一剂或两剂口服霍乱死疫苗后的抗原特异性记忆B细胞反应以及与自然感染霍乱患者反应的比较。
Clin Vaccine Immunol. 2011 May;18(5):844-50. doi: 10.1128/CVI.00562-10. Epub 2011 Feb 23.
9
Mucosal immunologic responses in cholera patients in Bangladesh.孟加拉国霍乱患者的黏膜免疫反应。
Clin Vaccine Immunol. 2011 Mar;18(3):506-12. doi: 10.1128/CVI.00481-10. Epub 2011 Jan 19.
10
Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.在 21 三体综合征孕妇的早孕期血清中利用质谱技术发现并进行候选蛋白生物标志物的选择反应监测(SRM)。
J Proteome Res. 2011 Jan 7;10(1):133-42. doi: 10.1021/pr100153j. Epub 2010 Jun 4.